ArticleFrontiers in oncology2026
Case Report: Resectability-guided management of an indeterminate periduodenal spindle cell tumor initially suspected to be a gastrointestinal stromal tumor.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Duodenal mesenchymal spindle cell tumors are uncommon and may overlap radiologically with gastrointestinal stromal tumors (GISTs) and retroperitoneal lesions. We report a 55-year-old woman with abdominal discomfort, nausea, and vomiting. Contrast-enhanced computed tomography demonstrated an approximately 6.0 × 3.8 cm mass posterior to the pancreatic head that was interpreted as a probable duodenal stromal tumor. Gastroscopic biopsy was non-representative. Given the symptoms, tumor size, uncertain origin, and vascular proximity, surgical exploration was undertaken. The tumor was firm and densely adherent to the inferior vena cava, and pancreaticoduodenectomy was performed. Supplementary pathological review showed a submucosal spindle cell tumor with 2 mitoses per 50 high-power fields, hemorrhage and inflammatory exudates, focal infiltrative growth, and limited invasion of adjacent pancreatic tissue. DOG-1, CD117, desmin, and CD34 were negative; SMA was positive, and β-catenin showed only weak cytoplasmic staining without nuclear accumulation. The expanded panel remained insufficient for definitive lineage assignment, and the lesion was designated an unclassified duodenal mesenchymal spindle cell tumor with SMA expression. Four abdominal computed tomography examinations and one magnetic resonance imaging examination showed no definite recurrence or metastasis through May 28, 2025. This case illustrates the limitations of superficial biopsy and shows that management of an anatomically complex periduodenal tumor may need to integrate diagnostic uncertainty, resectability, vascular proximity, and operative safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.